| abstract |
Disclosed herein are synthetic nanostructures, pharmaceutical compositions, kits, or methods for treating a wide spectrum of diseases associated with high fat diets or high saturated fat intake (e.g., cardiovascular disease, steatosis, cancer, diabetes type II, etc.). The synthetic nanostructures and compositions are orally administered and target and act in the gut. |